north america cold plasma equipment Market

North America, the cold plasma equipment market, is anticipated to reach US$ 153.05 Mn in 2027 from US$ 47.07 Mn in 2019. The market is projected to grow with a CAGR of 16.0% from 2020-2027.

The cold plasma equipment market is growing primarily due to the rising use of cold plasma in medical treatment; increasing hospital-acquired infections (HAI), and others in the North American region that are boosting the market over the years. Restraining factors, such as adverse effects of cold plasma, and lack of reimbursement, are likely to damage the growth of the market in the coming years. On the other hand, growing R&D expenditure for growth in the healthcare market is expected to have a positive impact on the growth of the North America cold plasma equipment market in the coming years.

Cold Plasma Equipment is also called non-thermal plasma and used in a wide range of applications in various industries, including medical and biomedical industries. It is a powerful tool that is used to provide antimicrobial treatment for wounds and injuries. The Cold Plasma Equipment technology offers non-thermal treatment of cancer, dentistry, and others.

Cold plasma is proved very effective in biomedicine. Cold plasma is used in many treatments such as dermatology, wound healing, cancer, atmospheric plasma on diabetes-induced enzyme glycation, oxidative stress, disinfection, inflammation, and scar treatment. Cold plasma has the ability to kill pathogenic bacteria, including the drug-resistant bacteria,ria to avoid further infection, which helps to treat in chronic wounds. This accelerates the process of wound healing, which prevents further complications and related other discomforts. Although there are many other treatment methods for wound healing, it is expected that cold plasma therapy is one of the most effective treatments. Plasma sources that are used in plasma medicine are typically "low temperature" plasma sources operated at atmospheric pressure. In this context, the low temperature refers to temperatures similar to room temperature, usually slightly above. Increasing in cases of diabetes, wound, and other inflammation is growing the market. According to the International Diabetes Federation (IDF), in 2017, the number of people with diabetes in North America was approximately 46 million, which is expected to grow at 62 million in 2045. The rise in disease prevalence is around 35% during the forecast period.

Diabetes affects various parts of the body, especially feet. According to a recent Centers for Disease Control and Prevention (CDC) report, more than 100 million U.S. adults are now living with diabetes. The report finds that as of 2015, 30.3 million Americans ? 9.4 percent of the U.S. population ?have diabetes. Another 84.1 million have prediabetes, a condition that, if not treated, often leads to type 2 diabetes within five years. Diabetes was the seventh leading cause of death in the U.S. in 2015. Diabetic foot ulcers are sores that develop on the feet, and they can develop even from seemingly trivial injuries to the feet. Diabetic foot ulcers are a common cause of amputation due to diabetes. Due to a rise in the use of cold plasma to treat diabetic patients, in various kinds of treatment, it is likely to increase the cold plasma equipment market.

In 2019, the atmospheric cold plasma equipment accounted for the largest market share in the North American cold plasma equipment market. Atmospheric cold plasmas, also called non-thermal plasmas, have attracted greater attention for its unique advantage in a new specialized field, plasma medicine. Atmospheric cold plasma gives the possibly highest plasma density. It is a unique, non-thermal glow discharge plasma operating system at atmospheric pressure. Atmospheric cold plasma, however, can also be used for the treatment of viable tissues and thus has become a focus of medical research over the past years. Other than therapeutic applications, CAP is also used for surface modification and biological decontamination. A different type of atmospheric cold plasma devices has been developed and tested for medical research purposes. In sequence, these can be divided into direct discharge (DBD: dielectric barrier discharge) and indirect discharge. Atmospheric pressure plasma jet) devices. The atmospheric cold plasma is have become a new innovative way for so many medical applications, such as disinfection, cancer treatment, root canal treatment, wound healing, and other medical applications. The atmospheric cold plasma equipment segment is also estimated to mark the highest CAGR in the market during the forecast period, owing to the increasing technological development in healthcare.

In 2019, the wound healing segment held the most significant market share of the cold plasma equipment market by the application. This segment is also anticipated to hold a considerable portion of the market in 2027, owing to the patients suffering from chronic, non-healing wounds. The segment is also anticipated to witness growth at a significant rate during the forecast period.
Some of the significant primary and secondary sources for cold plasma equipment included in the report are World Health Organization (WHO), Food and Drug Administration (FDA), Centers for Disease Control and Prevention (CDC).